We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA ASKS PFIZER TO HALT MISLEADING ZYRTEC PROMOTIONS
FDA ASKS PFIZER TO HALT MISLEADING ZYRTEC PROMOTIONS
May 3, 2004
The FDA has asked Pfizer, in an untitled letter, to immediately stop disseminating some promotional materials for Zyrtec-D, because the company misbranded the drug by failing to properly disclose some contraindications and warnings contained in its approved labeling.